CD103+ cDC1 and endogenous CD8+ T cells are necessary for improved CD40L-overexpressing CAR T cell antitumor function

MLA

Nicholas F. Kuhn, et al. “CD103+ CDC1 and Endogenous CD8+ T Cells Are Necessary for Improved CD40L-Overexpressing CAR T Cell Antitumor Function.” Nature Communications, vol. 11, no. 1, Dec. 2020, pp. 1–10. EBSCOhost, https://doi.org/10.1038/s41467-020-19833-3.

APA

Nicholas F. Kuhn, Andrea V. Lopez, Xinghuo Li, Winson Cai, Anthony F. Daniyan, & Renier J. Brentjens. (2020). CD103+ cDC1 and endogenous CD8+ T cells are necessary for improved CD40L-overexpressing CAR T cell antitumor function. Nature Communications, 11(1), 1–10. https://doi.org/10.1038/s41467-020-19833-3

Chicago

Nicholas F. Kuhn, Andrea V. Lopez, Xinghuo Li, Winson Cai, Anthony F. Daniyan, and Renier J. Brentjens. 2020. “CD103+ CDC1 and Endogenous CD8+ T Cells Are Necessary for Improved CD40L-Overexpressing CAR T Cell Antitumor Function.” Nature Communications 11 (1): 1–10. doi:10.1038/s41467-020-19833-3.